3-iodobenzylguanidine has been researched along with Experimental Hepatoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altmann, A; Haberkorn, U; Kissel, M; Kübler, W; Mahmut, M; Peschke, P; Zitzmann, S | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Experimental Hepatoma
Article | Year |
---|---|
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Cloning, Molecular; Humans; Liver Neoplasms, Experimental; Male; Metabolic Clearance Rate; Neoplasm Transplantation; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins; Reference Values; Symporters; Tissue Distribution; Transduction, Genetic; Tumor Cells, Cultured | 2003 |